Progressive multifocal leukoencephalopathy in a patient with chronic lymphocytic leukaemia treated with alemtuzumab

BMJ Case Reports

Volumn , Issue , 2014, Pages

  Isidoro, Luís ^a   Pires, Paula ^b   Rito, Luís ^a   Cordeiro, Gustavo ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b Hospital Santo Espirito de Angra do Heroesmo   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CIDOFOVIR; IMMUNOGLOBULIN G; PREDNISOLONE;

AGED; ARTICLE; BRAIN BIOPSY; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG SAFETY; DRUG WITHDRAWAL; DYSARTHRIA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; JC VIRUS; LUMBAR PUNCTURE; NERVE CONDUCTION; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PARESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; VIRUS IDENTIFICATION; VIRUS INFECTION; WEAKNESS;

EID: 84892706368     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2013-201781     Document Type: Article

References (9)

1. Aksamit AJ Jr. Progressive multifocal leukoencephalopathy. Continuum Lifelong Learning Neurol 2012;18:1374-91.
2. Lopes da Silva R. Spectrum of neurologic complications in chronic lymphocytic leukemia. Clin Lymphoma Myeloma Leuk 2012;12:164-79.
3. Cohen JA, Coles AJ, Arnold DL, et al. Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial. Lancet 2012;380:1819-28.
4. Coles AJ, Twyman CL, Arnold DL, et al. Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial. Lancet 2012;380:1829-39.
5. D'Souza A, Wilson J, Mukherjee S, et al. Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia: a report of three cases and review of literature. Clin Lymphoma Myeloma Leuk 2010;4:e2012043.
6. Martin S, Marty F, Fiumara K, et al. Infectious complications associated with alemtuzumab use for lymphoproliferative disorders. Clin Infect Dis 2006;43:16-24.
7. Waggoner J, Martinu T, Palmer SM. Progressive multifocal leukoencephalopathy following heightened immunosuppression after lung transplant. J Heart Lung Transplant 2009;28:395-8.
8. Keene DL, Legare C, Taylor E, et al. Monoclonal antibodies and progressive multifocal leukoencephalopathy. Can J Neurol Sci 2011;38:565-71.
9. Biogen Idec Medical Affairs. TYSABRI (natalizumab) Benefit/Risk Update & PML Risk Stratification Information for Healthcare Professionals, Update June 2013, 2013.